{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "pubchem:17513",
      "entity_text" : "AICAR",
      "entity_type" : "simple_chemical"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:P03973",
      "entity_text" : "ALP",
      "features" : [ {
        "modification_type" : "unknown",
        "feature_type" : "modification"
      } ],
      "entity_type" : "gene_or_gene_product"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "AICAR significantly promoted the mRNA expression levels of ALP, OCN and Runx2 in a dose dependent manner, whereas compound C, the AMPK inhibitor, reversed the effects of AICAR (XREF_FIG).",
  "reading_complete" : "2020-08-03T14:11:17Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T14:10:11Z",
  "trigger" : "reversed",
  "evidence" : [ "ALP, OCN and Runx2 in a dose-dependent manner, whereas compound C, the AMPK inhibitor, reversed the effects of AICAR" ],
  "pmc_id" : "5846672",
  "score" : 0
}